Corpay Second Quarter 2025 Earnings: In Line With Expectations

Explore Corpay's Fair Values from the Community and select yours

Corpay (NYSE:CPAY) Second Quarter 2025 Results

Key Financial Results

• Revenue: US$1.10b (up 13% from 2Q 2024).
• Net income: US$284.2m (up 13% from 2Q 2024).
• Profit margin: 26% (in line with 2Q 2024).
• EPS: US$4.03 (up from US$3.59 in 2Q 2024).

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Corpay Meets Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) was also in line with analyst expectations.

Looking ahead, revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 5.4% growth forecast for the Diversified Financial industry in the US.

Performance of the American Diversified Financial industry.

The company's shares are down 5.7% from a week ago.

Risk Analysis

You should learn about the 1 warning sign we've spotted with Corpay.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.